Status:
COMPLETED
Symbicort Onset of Action 1
Lead Sponsor:
AstraZeneca
Conditions:
Asthma
Eligibility:
All Genders
18+ years
Phase:
PHASE3
Brief Summary
The purpose of this study is to compare the early onset of effect of Symbicort compared to Advair Diskus and Ventolin in adults with asthma
Eligibility Criteria
Inclusion
- Diagnosis of asthma and baseline lung function test results as determined by protocol
- Required and received asthma maintenance therapy within previous 4 weeks at doses determined by protocol
Exclusion
- Severe asthma or asthma markedly affected by seasonal factors
- Has required treatment with any non-inhaled corticosteroids within previous 4 weeks, has sensitivity to drugs specified in the protocol or requires treatment with beta-blockers
Key Trial Info
Start Date :
April 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 1 2003
Estimated Enrollment :
48 Patients enrolled
Trial Details
Trial ID
NCT00646620
Start Date
April 1 2003
End Date
September 1 2003
Last Update
April 6 2009
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.